{
    "clinical_study": {
        "@rank": "33408", 
        "arm_group": {
            "arm_group_label": "1", 
            "description": "Patients previously included in the initial protocol WYETH 3074A1-4448 / B1811030. (To collect only status survival data 30 days after the last dose of treatment)"
        }, 
        "brief_summary": {
            "textblock": "The goal of this retrospective observational study is to collect only status survival data\n      30 days after the last dose of treatment of patients included in the initial protocol WYETH\n      3074A1-4448 / B1811030. The purpose is to estimate the survival status, 30 days after the\n      last intake of tigecycline to patients hospitalized in ICU and treated by tigecycline."
        }, 
        "brief_title": "Retrospective Transverse Observational Study Of Previous Study (Initial Protocol, B1811030)", 
        "completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "condition": "Survival Status at Day 30 After the Last Intake", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  All patients included in the previous study WYETH 3074A1-4448 then Pfizer B1811030\n             for which mortality status was not known at the closure of this previous study\n\n        Exclusion Criteria:\n\n          -  Patients who has withdrawn their consent for the study WYETH3074A1-4448 then Pfizer\n             B1811030."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "- Patients which has already been enrolled in the previous study protocol initial WYETH\n        3074A1-4448 then Pfizer B1811030"
            }
        }, 
        "enrollment": {
            "#text": "156", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 22, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01840319", 
            "org_study_id": "NRB1810005"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 9, 2014", 
        "link": {
            "description": "To obtain contact information for a study center near you, click here.", 
            "url": "https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=NRB1810005&StudyName=Retrospective%20Transverse%20Observational%20Study%20Of%20Previous%20Study%20%28Initial%20Protocol%2C%20B1811030%29"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Amiens Cedex 1", 
                        "country": "France", 
                        "zip": "80054"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Argenteuil", 
                        "country": "France", 
                        "zip": "95100"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ars Laquenexy", 
                        "country": "France", 
                        "zip": "57530"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Besancon cedex", 
                        "country": "France", 
                        "zip": "25030"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bordeaux", 
                        "country": "France", 
                        "zip": "33000"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bordeaux Cedex", 
                        "country": "France", 
                        "zip": "33076"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Clermont Ferrand Cedex", 
                        "country": "France", 
                        "zip": "63003"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Clermont-Ferrand", 
                        "country": "France", 
                        "zip": "63003"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "La Tronche", 
                        "country": "France", 
                        "zip": "38700"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Le Chesnay cedex", 
                        "country": "France", 
                        "zip": "78157"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Le Kremlin Bicetre", 
                        "country": "France", 
                        "zip": "94275"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Marseille", 
                        "country": "France", 
                        "zip": "13385"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Marseille Cedex 20", 
                        "country": "France", 
                        "zip": "13915"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Montpellier", 
                        "country": "France", 
                        "zip": "34295"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nantes Cedex 1", 
                        "country": "France", 
                        "zip": "44093"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nice cedex 1", 
                        "country": "France", 
                        "zip": "06006"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris Cedex 18", 
                        "country": "France", 
                        "zip": "75877"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rennes Cedex 9", 
                        "country": "France", 
                        "zip": "35033"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rouen Cedex", 
                        "country": "France"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Saint Etienne Cedex 02", 
                        "country": "France", 
                        "zip": "42055"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Strasbourg", 
                        "country": "France", 
                        "zip": "67200"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toulouse", 
                        "country": "France"
                    }, 
                    "name": "Pfizer Investigational Site"
                }
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_groups": "1", 
        "official_title": "Retrospective Observational Study Of Patients Previously Treated With Tigecycline In ICU And Included In The Previous French Prospective Observational Study", 
        "overall_official": {
            "affiliation": "Pfizer", 
            "last_name": "Pfizer CT.gov Call Center", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "France: French Data Protection Authority", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Survival Status at day 30 after last dose of treatment.", 
            "measure": "Alive/Not alive", 
            "safety_issue": "No", 
            "time_frame": "UNKNOWN"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01840319"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Pfizer", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Pfizer", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "October 2013"
    }
}